Cargando…
Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
BACKGROUND: The biodegradable polymer drug-eluting stents (DES) were developed to improve vascular healing. However, further data and longer-term follow-up are needed to confirm safety and efficacy of these stents. This randomized clinical trial aimed to compare safety and efficacy of 2 sirolimus-el...
Autores principales: | Zhang, Haijun, Wang, Xiangfei, Deng, Wei, Wang, Shenguo, Ge, Junbo, Toft, Egon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044893/ https://www.ncbi.nlm.nih.gov/pubmed/27661023 http://dx.doi.org/10.1097/MD.0000000000004820 |
Ejemplares similares
-
Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer
por: Seo, Kyoung-Woo, et al.
Publicado: (2021) -
Clinical and Angiographic Outcomes of the First Korean-made Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable Polymer
por: Yang, Hyoung-Mo, et al.
Publicado: (2017) -
An abluminal biodegradable polymer sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients undergoing coronary revascularization: 3-year clinical outcomes of a randomized non-inferiority trial
por: Zhang, Haijun, et al.
Publicado: (2019) -
Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice
por: Krackhardt, Florian, et al.
Publicado: (2020) -
Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020)